20. Ministry of Health of the Russian Federation. Clinical recommendations from 2021 «Menopause and menopausal condition in women». Access mode: https://cr.minzdrav.gov.ru/recomend/117_2. Date of application: 20.12.2022. URL: https://cr.minzdrav.gov.ru/recomend/117_2 (date of access December 20, 2022) (in Russian)
21. Ministry of Health of the Russian Federation. Clinical recommendations from 2021 «Vitamin D deficiency». URL: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/kr_deficit_vitamina_d_2021.pdf (date of access December 27, 2022) (in Russian)
22. Pludowski P., Holick M.F., Grant W.B., et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018; 175: 125–35. DOI: https://doi.org/10.1016/j.jsbmb.2017.01.021
23. Carlberg C. Vitamin D in the context of evolution. Nutrients. 2022; 14 (15): 3018. DOI: https://doi.org/10.3390/nu14153018 PMID: 35893872; PMCID: PMC9332464.
24. Henn M., Martin-Gorgojo V., Martin-Moreno J.M. Vitamin D in cancer prevention: Gaps in current knowledge and room for hope. Nutrients. 2022; 14 (21): 4512. DOI: https://doi.org/10.3390/nu14214512
25. Grant W.B., Boucher B.J., Al Anouti F., Pilz S. Comparing the evidence from observational studies and randomized controlled trials for nonskeletal health effects of vitamin D. Nutrients. 2022; 14 (18): 3811. DOI: https://doi.org/10.3390/nu14183811
26. Muñoz A., Grant W.B. Vitamin D and cancer: An historical overview of the epidemiology and mechanisms. Nutrients. 2022; 14 (7): 1448. DOI: https://doi.org/10.3390/nu14071448
27. Zhang Y., Fang F., Tang J., et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019; 366: l4673. DOI: https://doi.org/10.1136/bmj.l4673
28. McDonnell S.L., Baggerly C.A., French C.B., et al. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS One. 2018; 13 (6): e0199265. DOI: https://doi.org/10.1371/journal.pone.0199265
29. Mohammadi R., Tabrizi R., Hessami K., et al. Correlation of low serum vitamin-D with uterine leiomyoma: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2020; 18 (1): 85.
30. Qiu Y., Yuan S., Wang H. Vitamin D status in endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020; 302 (1): 141–52. DOI: https://doi.org/10.1007/s00404-020-05576-5
31. Orazov M.R., Radzinsky V.E., Khamoshina M.B., et al. Vitamin D3 (cholecalciferol) and pelvic pain induced by ovarian endometriosis. Trudniy patsient [Difficult Patient]. 2018; 16 (4): 34–9. (in Russian)
32. Zatvornitskaya A.V. Features of vitamin D status and expression of vitamin D receptors in the uterine mucosa in patients with endometrial hyperplasia associated with chronic endometritis. Vestnik soveta molodykh uchenykh i spetsialistov Chelyabinskoy oblasti [Bulletin of the Council of Young Scientists and Specialists of the Chelyabinsk Region]. 2019; 2 (2): 24–8. (in Russian)
33. Tomio K., Kawana K., Taguchi A., et al. Omega-3 polyunsaturated fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS One. 2013; 8 (9): e73085.
34. Missmer S.A., Chavarro J.E., Malspeis S., et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010; 25 (6): 1528–35.
35. Jurkiewicz-Przondziono J., Lemm M., Kwiatkowska-Pamuła A., et al. Influence of diet on the risk of developing endometriosis. Ginekol Pol. 2017; 88 (2): 96–102. DOI: https://doi.org/10.5603/GP.a2017.0017
36. Bikle D.D. Vitamin D: Production, Metabolism and Mechanisms of Action. In: K.R. Feingold, B. Anawalt, A. Boyce, et al. (eds). Endotext South Dartmouth, MA: MDText.com, Inc., December 31, 2021.
37. Chang S.W., Lee H.C. Vitamin D and health – the missing vitamin in humans. Pediatr Neonatol. 2019; 60 (3): 237–44. DOI: https://doi.org/10.1016/j.pedneo.2019.04.007
38. Szymczak-Pajor I., Drzewoski J., Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020; 21 (18): 6644. DOI: https://doi.org/10.3390/ijms21186644
39. Niroomand M., Fotouhi A., Irannejad N., Hosseinpanah F. Does high-dose vitamin D supplementation impact insulin resistance and risk of development of diabetes in patients with pre-diabetes? A double-blind randomized clinical trial. Diabetes Res Clin Pract. 2019; 148: 1–9. DOI: https://doi.org/10.1016/j.diabres.2018.12.008
40. Zarei M., Zarezadeh M., Hamedi Kalajahi F., Javanbakht M.H. The relationship between vitamin D and telomere/telomerase: A comprehensive review. J Frailty Aging. 2021; 10 (1): 2–9. DOI: https://doi.org/10.14283/jfa.2020.33
41. Ciulei G., Orasan O.H., Coste S.C., et al. Vitamin D and the insulin-like growth factor system: Implications for colorectal neoplasia. Eur J Clin Invest. 2020; 50 (9): e13265. DOI: https://doi.org/10.1111/eci.13265
42. Carlberg C., Muñoz A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2022; 79: 217–30. DOI: https://doi.org/10.1016/j.semcancer.2020.05.018
43. Deuster E., Jeschke U., Ye Y., et al. Vitamin D and VDR in gynecological cancers: A systematic review. Int J Mol Sci. 2017; 18 (11): 2328. DOI: https://doi.org/10.3390/ijms18112328
44. Yan L., Gu Y., Luan T., et al. Associations between serum vitamin D and the risk of female reproductive tumors: A meta-analysis with trial sequential analysis. Medicine (Baltimore). 2018; 97 (15): e0360. DOI: https://doi.org/10.1097/MD.0000000000010360
45. Román M., Louro J., Posso M., et al. Breast density, benign breast disease, and risk of breast cancer over time. Eur Radiol. 2021; 31 (7): 4839–47. DOI: https://doi.org/10.1007/s00330-020-07490-5
46. Mal’tseva L.I., Garifullova Yu.V., Kalinkina M.G. The role of vitamin D in reducing breast density in women with diffuse mastopathy. Prakticheskaya meditsina [Practical Medicine]. 2018; (6): 111–7. (in Russian)
47. Cermisoni G.C., Alteri A., Corti L., et al. Vitamin D and endometrium: A systematic review of a neglected area of research. Int J Mol Sci. 2018; 19 (8): 2320. DOI: https://doi.org/10.3390/ijms19082320
48. Nigam A., Frasure-Smith N., Lespérance F., Julien P. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009; 19 (4): 264–70. DOI: https://doi.org/10.1016/j.numecd.2008.07.008
49. Russian Society of Obstetricians and Gynecologists. All-Russian public organization «Russian Society of Oncomammologists». Russian Association of Mammologists. Clinical recommendations «Benign breast dysplasia». Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. 2020: 77 p. (in Russian)
50. Mal’tseva L.I., Garifullova Yu.V. The role of vitamin D provision in the formation of risk and progression of mastopathy in women. Prakticheskaya meditsina [Practical Medicine]. 2016; 1 (93): 58–62. (in Russian)
51. Płudowski P., Karczmarewicz E., Bayer M., et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64 (4): 319–27. DOI: https://doi.org/10.5603/ep.2013.0012
52. Cesareo R., Attanasio R., Caputo M., et al.; AME and Italian AACE Chapter. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical management of vitamin D deficiency in adults. Nutrients. 2018; 10 (5): 546. DOI: https://doi.org/10.3390/nu10050546
53. Mansouri M., Abasi R., Nasiri M., et al. Association of vitamin D status with metabolic syndrome and its components: A cross-sectional study in a population of high educated Iranian adults. Diabetes Metab Syndr. 2018; 12 (3): 393–8. DOI: https://doi.org/10.1016/j.dsx.2018.01.007
54. Oh D.Y., Talukdar S., Bae E.J., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142 (5): 687–98. DOI: https://doi.org/10.1016/j.cell.2010.07.041
55. Yang K., Zeng L., Bao T., Ge J. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018; 16 (1): 27. DOI: https://doi.org/10.1186/s12958-018-0346-x
56. URL: https://portal.eaeunion.org/sites/odata/_layouts/15/Portal.EEC.Registry.UI/DisplayForm.aspx?ItemId=10873755&ListId=f7954aaa-b57b-429e-8f39-b7e3158c88d6
57. Marchenkova L.A., Makarova E.V., Yurova O.V. The role of micronutrients in the comprehensive rehabilitation of patients with the novelcoronavirus infection COVID-19. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (2): 40–9. DOI: https://doi.org/10.33029/0042-8833-2021-90-2-40-49 (in Russian)
58. URL: https://apteka.ru/product/detrimarin-60-sht-kapsuly-massoj-700-mg-603ccc7b8252e4658d1dfe49/?q=детримарин